NCT03739970

A Clinical Trial of Silk Peptide for the Evaluation of Efficacy on Immune Function

A Clinical Trial of Silk Peptide for the Evaluation of Efficacy on Immune Function Enhancement

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 110 (estimated)
• Sponsor: Yonsei University · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Accepted

Summary

This study is a 8-week, randomized, double-blind, placebo-controlled clinical trial of Silk Peptide for the evaluation of efficacy on immune function enhancement.

Detailed description

This study will evaluate Silk Peptide's efficacy on immune function in healthy volunteers who white blood cells count is in between 4000/㎕ and 8000/㎕ by assessing improvements in certain immune indices (i.e. NK cell activity, IFN-γ, TNF-α, IL-1β, 2, 12, IgG1, IgG2).

Conditions

• Normal Healthy Subjects

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Investigational Product (Silk Peptide)	* Ingredient: Silk Peptide * Type: Yellow granule stick * Storage: Room temperature * Weight: Silk Peptide 9g/day * Directions: with water before breakfast and dinner, 9g/day (4.5g×2times/day) * Duration of use: 8 weeks
DIETARY_SUPPLEMENT	Control Group - Placebo Product	* Ingredient: Microcrystalline Cellulose * Type: Yellow granule stick * Storage: Room temperature * Weight: Silk Peptide 0g/day * Directions: with water before breakfast and dinner, 9g/day (4.5g×2times/day) * Duration of use: 8 weeks

Timeline

• Start date: 2018-11-15
• Primary completion: 2019-01-29
• Completion: 2019-02-28
• First posted: 2018-11-14
• Last updated: 2018-11-14

Locations

1 site across 1 country: South Korea